MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$6,229K
Net Income
-$50,661K
Net Profit Margin
-813.31%
EPS
-$0.79
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
6,229 1,402 10,632 13,817
Research and development
39,673 41,695 37,696 25,855
General and administrative
NaN NaN NaN 15,262
Sales, general and administrative
19,974 21,146 16,027 NaN
Total operating expenses
59,647 62,841 53,723 41,117
(loss) income from operations
-53,418 -61,439 -43,091 -27,300
Interest income (expense), net
3,397 3,615 3,463 3,789
Other income
18 -110 3 28
Total other income (expense)
3,415 3,505 3,466 3,817
(loss) income before income taxes
-50,003 NaN -39,625 -23,483
Provision for income taxes
0 NaN -1,278 0
Net (loss) income
-50,003 -57,934 -38,347 -23,483
Unrealized (loss) gain on marketable securities
-658 97 350 200
Total other comprehensive (loss) gain
-658 97 350 200
Comprehensive (loss) income
-50,661 -57,837 -37,997 -23,283
Basic EPS
-0.79 -0.932 -0.65 -0.4
Diluted EPS
-0.79 -0.956 -0.65 -0.4
Basic Average Shares
63,063,507 62,048,530 58,611,677 58,353,855
Diluted Average Shares
63,063,507 60,512,604 58,611,677 58,353,855
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive (loss) income-$50,661K (-144.86%↓ Y/Y)Net (loss) income-$50,003K (-144.30%↓ Y/Y)Total othercomprehensive (loss) gain-$658K (-1500.00%↓ Y/Y)Interest income(expense), net$3,397K (17.58%↑ Y/Y)Other income$18K (-35.71%↓ Y/Y)(loss) income beforeincome taxes-$50,003K (-143.80%↓ Y/Y)Unrealized (loss) gain onmarketable securities-$658K (-1500.00%↓ Y/Y)Total other income(expense)$3,415K (17.07%↑ Y/Y)(loss) income fromoperations-$53,418K (-148.02%↓ Y/Y)Revenue$6,229K (-96.07%↓ Y/Y)Total operatingexpenses$59,647K (26.03%↑ Y/Y)Research and development$39,673K (21.41%↑ Y/Y)Sales, general andadministrative$19,974K

Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics, Inc. (STOK)